Chewability testing in the development of a chewable tablet for hyperphosphatemia.
about
Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide.Iron-based phosphate binders--a new element in management of hyperphosphatemia.Sucroferric oxyhydroxide: a review in hyperphosphataemia in chronic kidney disease patients undergoing dialysis.Novel iron-containing phosphate binders for treatment of hyperphosphatemia.Phosphate binders in patients with chronic kidney disease.Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients?
P2860
Chewability testing in the development of a chewable tablet for hyperphosphatemia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Chewability testing in the development of a chewable tablet for hyperphosphatemia.
@ast
Chewability testing in the development of a chewable tablet for hyperphosphatemia.
@en
Chewability testing in the development of a chewable tablet for hyperphosphatemia.
@nl
type
label
Chewability testing in the development of a chewable tablet for hyperphosphatemia.
@ast
Chewability testing in the development of a chewable tablet for hyperphosphatemia.
@en
Chewability testing in the development of a chewable tablet for hyperphosphatemia.
@nl
prefLabel
Chewability testing in the development of a chewable tablet for hyperphosphatemia.
@ast
Chewability testing in the development of a chewable tablet for hyperphosphatemia.
@en
Chewability testing in the development of a chewable tablet for hyperphosphatemia.
@nl
P2093
P1476
Chewability testing in the development of a chewable tablet for hyperphosphatemia.
@en
P2093
Burkhard Kriwet
Georgios Imanidis
Jan Baldischweiler
John Stafford
Jutta Schill
Michael Lanz
P304
P356
10.3109/03639045.2013.838583
P407
P577
2013-09-06T00:00:00Z